A c-Jun N-terminal kinase inhibitor, JNK-IN-8, sensitizes triple negative breast cancer cells to lapatinib.
about
A c-Jun N-terminal kinase inhibitor, JNK-IN-8, sensitizes triple negative breast cancer cells to lapatinib.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
A c-Jun N-terminal kinase inhi ...... ast cancer cells to lapatinib.
@en
A c-Jun N-terminal kinase inhi ...... ast cancer cells to lapatinib.
@nl
type
label
A c-Jun N-terminal kinase inhi ...... ast cancer cells to lapatinib.
@en
A c-Jun N-terminal kinase inhi ...... ast cancer cells to lapatinib.
@nl
prefLabel
A c-Jun N-terminal kinase inhi ...... ast cancer cells to lapatinib.
@en
A c-Jun N-terminal kinase inhi ...... ast cancer cells to lapatinib.
@nl
P2093
P2860
P356
P1433
P1476
A c-Jun N-terminal kinase inhi ...... east cancer cells to lapatinib
@en
P2093
Carla L Van Den Berg
Nancy D Ebelt
Ramakrishna Edupuganti
Sabrina Van Ravenstein
Tamer S Kaoud
P2860
P304
104894-104912
P356
10.18632/ONCOTARGET.20581
P407
P577
2017-08-24T00:00:00Z